These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25000479)

  • 1. Activation of IK1 by zacopride: amelioration of left ventricular remodeling, but at what risk?
    Curtis MJ
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):343-4. PubMed ID: 25000479
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of IK1 channel by zacopride attenuates left ventricular remodeling in rats with myocardial infarction.
    Liu CF; Liu QH; Liu EL; Zhai XW; Zhang L; Luo TE; Zhang WF; Feng QL; Cui XL; Zhao ZQ; Cao JM; Wu BW
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):345-56. PubMed ID: 25286360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of zacopride, a moderate I
    Elnakish MT; Canan BD; Kilic A; Mohler PJ; Janssen PM
    Pharmacol Res; 2017 Jan; 115():309-318. PubMed ID: 27914945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel discovery of IK1 channel agonist: zacopride selectively enhances IK1 current and suppresses triggered arrhythmias in the rat.
    Liu QH; Li XL; Xu YW; Lin YY; Cao JM; Wu BW
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):37-48. PubMed ID: 21921806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IK1/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat.
    Zhai XW; Zhang L; Guo YF; Yang Y; Wang DM; Zhang Y; Li P; Niu YF; Feng QL; Wu BW; Cao JM; Liu QH
    PLoS One; 2017; 12(5):e0177600. PubMed ID: 28542320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the risk concerns of zacopride, a moderate IK1 channel agonist with cardiac protective action.
    Wu BW; Cao JM
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):357-9. PubMed ID: 25072868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I
    Zhai X; Qiao X; Zhang L; Wang D; Zhang L; Feng Q; Wu B; Cao J; Liu Q
    Life Sci; 2019 Dec; 239():117075. PubMed ID: 31751587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Agonist of Inward Rectifier Potassium Channel (I
    Liu Q; Sun J; Zhang L; Xu Y; Wu B; Cao J
    Int Heart J; 2021; 62(6):1348-1357. PubMed ID: 34853227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opening of the inward rectifier potassium channel alleviates maladaptive tissue repair following myocardial infarction.
    Liu C; Liu E; Luo T; Zhang W; He R
    Acta Biochim Biophys Sin (Shanghai); 2016 Aug; 48(8):687-95. PubMed ID: 27486024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zacopride selectively activates the Kir2.1 channel via a PKA signaling pathway in rat cardiomyocytes.
    Zhang L; Liu Q; Liu C; Zhai X; Feng Q; Xu R; Cui X; Zhao Z; Cao J; Wu B
    Sci China Life Sci; 2013 Sep; 56(9):788-96. PubMed ID: 23929001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical defibrillation in acute myocardial ischaemia: a hypothesis.
    Curtis MJ
    J Basic Clin Physiol Pharmacol; 1994; 5(1):1-17. PubMed ID: 8736067
    [No Abstract]   [Full Text] [Related]  

  • 12. Berberine elicits anti-arrhythmic effects via IK1/Kir2.1 in the rat type 2 diabetic myocardial infarction model.
    Wang LH; Yu CH; Fu Y; Li Q; Sun YQ
    Phytother Res; 2011 Jan; 25(1):33-7. PubMed ID: 20623609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
    Fraccarollo D; Widder JD; Galuppo P; Thum T; Tsikas D; Hoffmann M; Ruetten H; Ertl G; Bauersachs J
    Circulation; 2008 Aug; 118(8):818-27. PubMed ID: 18678774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tedisamil. KC 8857.
    Drugs R D; 1999 Apr; 1(4):327-30. PubMed ID: 10566055
    [No Abstract]   [Full Text] [Related]  

  • 15. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction.
    St John Sutton M; Lee D; Rouleau JL; Goldman S; Plappert T; Braunwald E; Pfeffer MA
    Circulation; 2003 May; 107(20):2577-82. PubMed ID: 12732606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renzapride in IBS: is efficacy in the eye of the beholder?
    Ford AC
    Aliment Pharmacol Ther; 2010 Jul; 32(1):113-4; author reply 114-5. PubMed ID: 20597877
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation of SUR2B/Kir6.1 subtype of adenosine triphosphate-sensitive potassium channel improves pressure overload-induced cardiac remodeling via protecting endothelial function.
    Tang Y; Long CL; Wang RH; Cui W; Wang H
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):345-53. PubMed ID: 20505525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tedisamil (Solvay).
    Flores NA
    Curr Opin Investig Drugs; 2001 Jan; 2(1):97-103. PubMed ID: 11527020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment of the gastric symptoms of radiation sickness.
    Dubois A; Fiala N; Boward CA; Bogo V
    Radiat Res; 1988 Sep; 115(3):595-604. PubMed ID: 3174940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation: emerging possibilities for drug treatment: an overview of current opportunities and recent developments.
    Papp JG; Singh BN
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8 Suppl 1():S1-3. PubMed ID: 12746746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.